Author:
Faheem Shaima M.,Osman Hiam M.,El-Tabl Abdou S.,Abd-El Wahed Moshira M.,Younes Sara M.
Abstract
AbstractCancer, a lethal ailment, possesses a multitude of therapeutic alternatives to combat its presence, metal complexes have emerged as significant classes of medicinal compounds, exhibiting considerable biological efficacy, especially as anticancer agents. The utilization of cis-platin in the treatment of various cancer types, including breast cancer, has served as inspiration to devise novel nanostructured metal complexes for breast cancer therapy. Notably, homo- and hetero-octahedral bimetallic complexes of an innovative multifunctional ether ligand (comprising Mn(II), Ni(II), Cu(II), Zn(II), Hg(II), and Ag(I) ions) have been synthesized. To ascertain their structural characteristics, elemental and spectral analyses, encompassing IR, UV–Vis, 1H-NMR, mass and electron spin resonance (ESR) spectra, magnetic moments, molar conductance, thermal analysis, and electron microscopy, were employed. The molar conductance of these complexes in DMF demonstrated a non-electrolytic nature. Nanostructured forms of the complexes were identified through electron microscopic data. At ambient temperature, the ESR spectra of the solid complexes exhibited anisotropic and isotropic variants, indicative of covalent bonding. The ligand and several of its metal complexes were subjected to cytotoxicity testing against breast cancer protein 3S7S and liver cancer protein 4OO6, with the Ag(I) complex (7) evincing the most potent effect, followed by the Cu(II) with ligand (complex (2)), Cis-platin, the ligand itself, and the Cu(II)/Zn(II) complex (8). Molecular docking data unveiled the inhibitory order of several complexes.
Funder
Ministry of Higher Education & Scientific Research Egypt
Publisher
Springer Science and Business Media LLC
Reference62 articles.
1. El-Tabl, A. S., Abd-Elzaher, F. A., Shakdofa, M. M. E., Rasras, M. M. & Anas, J. Synthesis, physicochemical studies and biological evaluation of unimetallic and heterobimetallic complexes of hexadentatedihydrazone ligands. Beni-Suef Univ. J. Basic Appl. Sci. 6(1), 24–32 (2017).
2. El-Tabl, A. S. et al. Synthesis, structural characterization, electrochemical and biological studies on divalent metal chelates of a new ligand derived from pharmaceutical preservative, dehydroacetic acid, with 1, 4-diaminobenzene. Arab. J. Chem. 10, S3816–S3825 (2017).
3. El-Tabl, A. S., Abd-El Wahed, M. M. & Abu-Setta, M. H. H. Metallo-bioactive compounds as potential novel anticancer therapy. J. Chem. Chem. Sci. 4, 17–31 (2015).
4. El-Tabl, A. S. et al. Synthesis, structural characterization and study of some new antimicrobial action of metal complexes of (E)-N’, N’’-bis ((Z)-4-fluorobenzylidene)-2- (naphthalen-1-yloxy) acetohydrazono-hydrazide Schiff Base. J. Chem. Chem. Sci. 6(6), 513–536 (2016).
5. El-Tabl, A. S., Abd-El Wahed, M. M. & Hashim, S. M. F. Metal chelates as antitumor agents: Synthesis, spectroscopic characterization and cytotoxic action of metal chelates of new dioxime ligand. J. Chem. Chem. Sci. 8, 1026–1047 (2018).